GAITHERSBURG, Md. (AP) _ Novavax Inc. (NVAX) on Wednesday reported a loss of $31.8 million in its fourth quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $1.13.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.08 per share.
The vaccine maker posted revenue of $8.8 million in the period.
For the year, the company reported that its loss narrowed to $132.7 million, or $5.51 per share. Revenue was reported as $18.7 million.
Novavax shares have more than doubled since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $10.51, an increase of slightly more than 3% in the last 12 months.